Appili Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Appili Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 41% to $827,407. The net income raised on -$3,780,910 and profit margin reached -457%. Total operating expenses were $8,836,947.
Profit Margin
| 2018 | 0 | -3.97M | |
|---|---|---|---|
| 2019 | 0 | -4.33M | |
| 2021 | 0 | -14.32M | |
| 2022 | 1.39M | -25.11M | -1806.18% |
| 2024 | 827.40K | -3.78M | -456.96% |
APLI.TO Income Statement (2017 – 2023)
| 2023 | 2021 | 2020 | 2018 | 2017 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 827.40K | 1.39M | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 14.83K | 20.71K | 17.67K |
Gross profit | 827.40K | 1.39M | -14.83K | -20.71K | -17.67K |
Operating exp. | |||||
Research and development | 5.62M | 21.45M | 11.49M | 3.32M | 4.94M |
Selling and marketing | 143.62K | 711.93K | 650.19K | 861.44K | 735.00K |
Total operating expenses | 8.83M | 24.94M | 16.28M | 4.37M | 3.76M |
Operating income | -8.05M | -24.67M | -16.29M | -6.54M | -3.76M |
Other income (expenses), net | 4.33M | -401.35K | 1.34M | 2.21M | -254.87K |
Income before tax | -3.71M | -25.07M | -14.95M | -4.33M | -3.97M |
Income tax expense | 69.58K | 38.45K | -627.89K | -621.60K | -46.18K |
Net income | -3.78M | -25.11M | -14.32M | -4.33M | -3.97M |
Earnings per share | |||||
Basic EPS | -0.03 | -0.38 | -0.24 | -0.14 | -0.12 |
Diluted EPS | -0.03 | -0.38 | -0.24 | -0.14 | -0.12 |
| Data source | Data source | Data source | Data source | Data source |